Fanni Li Selected Research

LZ-207

1/2015

LZ-207, a Newly Synthesized Flavonoid, Induces Apoptosis and Suppresses Inflammation-Related Colon Cancer by Inhibiting the NF-κB Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fanni Li Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 12/2011
6	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2011
4	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 01/2014
4	Breast Neoplasms (Breast Cancer) 01/2014 - 03/2012
3	Klatskin Tumor 07/2020 - 01/2015
2	Cholangiocarcinoma 07/2020 - 01/2018
2	Lymphatic Metastasis 07/2020 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2018
2	Inflammation (Inflammations) 11/2019 - 01/2015
2	Melanoma (Melanoma, Malignant) 01/2014 - 03/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Cognitive Dysfunction 01/2022
1	Adenocarcinoma 01/2021
1	Esophageal Squamous Cell Carcinoma 01/2020
1	Rheumatoid Arthritis 01/2020
1	Colitis 11/2019
1	Body Weight (Weight, Body) 11/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Infections 12/2017
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 01/2015
1	Colonic Neoplasms (Colon Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

6	IntegrinsIBA 01/2022 - 12/2011
5	FlavonoidsIBA 01/2015 - 03/2012
4	Peptides (Polypeptides)IBA 01/2021 - 01/2018
4	Messenger RNA (mRNA)IBA 06/2018 - 12/2011
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
2	Interleukin-8 (Interleukin 8)IBA 11/2019 - 01/2015
2	Antiviral Agents (Antivirals)IBA 12/2017 - 01/2014
2	Matrix Metalloproteinases (MMPs)IBA 01/2014 - 03/2012
2	gambogic acidIBA 12/2012 - 12/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022
1	SolutionsIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 07/2020
1	InflammasomesIBA 01/2020
1	acetyl 4-aminosalicylic acidIBA 01/2020
1	EnzymesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Anti-Citrullinated Protein AntibodiesIBA 01/2020
1	AutoantibodiesIBA 01/2020
1	eriocitrinIBA 11/2019
1	CytokinesIBA 11/2019
1	Dextran SulfateIBA 11/2019
1	isoquinolineIBA 01/2018
1	AlkaloidsIBA 01/2018
1	BerberineIBA 01/2018
1	AAA ProteinsIBA 01/2018
1	Blood Proteins (Serum Proteins)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018
1	Untranslated Regions (Untranslated Region)IBA 12/2017
1	Glycoproteins (Glycoprotein)IBA 12/2017
1	Metalloproteases (Metalloproteinases)IBA 12/2017
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 12/2017
1	3' Untranslated Regions (3' UTR)IBA 12/2017
1	LZ-207IBA 01/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	AntioxidantsIBA 01/2014
1	LFG-500IBA 01/2014
1	wogoninIBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 03/2012
1	xanthoneIBA 12/2011
1	ElementsIBA 12/2011
1	Acetyl-CoA C-Acetyltransferase (Acetyl Coenzyme A Acetyltransferase)IBA 12/2011
1	SterolsIBA 12/2011
1	Membrane LipidsIBA 12/2011
1	CholesterolIBA 12/2011
1	Fibronectins (Fibronectin)IBA 12/2011
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 12/2011

Therapy/Procedure

1	Immunotherapy 01/2021
1	Intravenous Administration 01/2020
1	Intraperitoneal Injections 01/2020
1	Therapeutics 06/2012